Walden – NURS 6630 Assignment 1 Short Answer Assessment
NURS 6630 Assignment 1 Short Answer Assessment
NURS 6630 Assignment 1 Short Answer Assessment
Assignment 1: Short Answer Assessment
As a psychiatric nurse practitioner, you will likely encounter patients who suffer from various mental health disorders. Not surprisingly, ensuring that your patients have the appropriate psychopharmacologic treatments will be essential for their overall health and well-being. The psychopharmacologic treatments you might recommend for patients may have potential impacts on other mental health conditions and, therefore, require additional consideration for positive patient outcomes. For this Assignment, you will review and apply your understanding of psychopharmacologic treatments for patients with multiple mental health disorders.
To Prepare NURS 6630 Assignment 1 Short Answer Assessment:
- Review the Learning Resources for this week.
- Reflect on the psychopharmacologic treatments that you have covered up to this point that may be available to treat patients with mental health disorders.
- Consider the potential effects these psychopharmacologic treatments may have on co-existing mental health conditions and/or their potential effects on your patient’s overall health.
To complete NURS 6630 Assignment 1 Short Answer Assessment Paper:
Address the following Short Answer prompts for your Assignment. Be sure to include references to the Learning Resources for this week.
- In 3 or 4 sentences, explain the appropriate drug therapy for a patient who presents with MDD and a history of alcohol abuse. Which drugs are contraindicated, if any, and why? Be specific. What is the timeframe that the patient should see resolution of symptoms?
- List 4 predictors of late onset generalized anxiety disorder.
- List 4 potential neurobiology causes of psychotic major depression.
- An episode of major depression is defined as a period of time lasting at least 2 weeks. List at least 5 symptoms required for the episode to occur. Be specific.
- List 3 classes of drugs, with a corresponding example for each class, that precipitate insomnia. Be specific.
By Day 7
This Assignment is due.
Get assistance with your nursing paper
NURS 6630 Assignment 1 Short Answer Assessment Submission and Grading Information
To submit your completed Assignment for review and grading, do the following:
- Please save your Assignment using the naming convention “WK8Assgn1+last name+first initial.(extension)” as the name.
- Click the Week 8 Assignment 1 Rubric to review the Grading Criteria for the Assignment.
- Click the Week 8 Assignment 1 link. You will also be able to “View Rubric” for grading criteria from this area.
- Next, from the Attach File area, click on the Browse My Computer button. Find the document you saved as “WK8Assgn1+last name+first initial.(extension)” and click Open.
- If applicable: From the Plagiarism Tools area, click the checkbox for I agree to submit my paper(s) to the Global Reference Database.
- Click on the Submit button to complete your submission.
Grading Criteria
To access your rubric:
Week 8 Assignment 1 Rubric
Check Your Assignment Draft for Authenticity
To check your Assignment draft for authenticity:
Submit your Week 8 Assignment 1 draft and review the originality report.
Submit Your Assignment by Day 7 of Week 8
To participate in this NURS 6630 Assignment 1 Short Answer Assessment Assignment:
Week 8 Assignment 1
Week 8: Therapy for Patients With Sleep/Wake Disorders
From negative changes in mood to problems concentrating, sleep/wake disorders can have a tremendous impact on patients’ lives. When patients suffer from these disorders, they often seek medical care with the intent of receiving medications to manage symptoms. However, many of the medications used to treat sleep/wake disorders may be addictive, making thorough patient assessments and close follow-up care essential. To prescribe appropriate therapies with patient safety in mind, you must understand not only the pathophysiology of these disorders but also the pharmacologic agents used to treat them.
This week, as you study therapies for individuals with sleep/wake disorders, you examine the assessment and treatment of patients with these disorders. You also explore ethical and legal implications of these therapies.
Learning Objectives
Students will:
- Synthesize concepts related to the psychopharmacologic treatment of patients
- Assess patient factors and history to develop personalized therapy plans for patients with sleep/wake disorders
- Analyze factors that influence pharmacokinetic and pharmacodynamic processes in patients requiring therapy for sleep/wake disorders
- Synthesize knowledge of providing care to patients presenting for sleep/wake disorders
- Analyze ethical and legal implications related to prescribing therapy for patients with sleep/wake disorders
Learning Resources
NURS 6630 Assignment 1 Short Answer Assessment Required Readings
American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders (5th ed.).
Fernandez-Mendoza, J., & Vgontzas, A. N. (2013). Insomnia and its impact on physical and mental health. Current Psychiatry Reports, 15(12), 418.
Levenson, J. C., Kay, D. B., & Buysse, D. J. (2015). The pathophysiology of insomnia. Chest, 147(4), 1179–1192.
Morgenthaler, T. I., Kapur, V. K., Brown, T. M., Swick, T. J., Alessi, C., Aurora, R. N., Boehlecke, B., Chesson, A. L., Friedman, L., Maganti, R., Owens, J., Pancer, J., & Zak, R. (2007). Practice parameters for the treatment of narcolepsy and other hypersomnias of central origin. SLEEP, 30(12), 1705–1711.
Morgenthaler, T. I., Owens, J., Alessi, C., Boehlecke, B, Brown, T. M., Coleman, J., Friedman, L., Kapur, V. K., Lee-Chiong, T., Pancer, J., & Swick, T. J. (2006). Practice parameters for behavioral treatment of bedtime problems and night wakings in infants and young children. SLEEP, 29(1), 1277–1281.
Sateia, M. J., Buysse, D. J., Krystal, A. D., Neubauer, D. N., & Heald, J. L. (2017). Clinical practice guideline for the pharmacologic treatment of chronic insomnia in adults: An American Academy of Sleep Medicine clinical practice guideline. Journal of Clinical Sleep Medicine, 13(2), 307–349.
Winkleman, J. W. (2015). Insomnia disorder. The New England Journal of Medicine, 373(15), 1437–1444.
Top nursing paper writers on hand to assist you with NURS 6630 Assignment 1 Short Answer Assessment
Medication Resources
U.S. Food & Drug Administration. (n.d.). Drugs@FDA: FDA-approved drugs.
Note: To access the following medications, use the Drugs@FDA resource. Type the name of each medication in the keyword search bar. Select the hyperlink related to the medication name you searched. Review the supplements provided and select the package label resource file associated with the medication you searched. If a label is not available, you may need to conduct a general search outside of this resource provided. Be sure to review the label information for each medication as this information will be helpful for your review in preparation for your Assignments.
|
|
Required Media
Case study: Pharmacologic approaches to the treatment of insomnia in a younger adult
Note: This case study will serve as the foundation for this week’s Assignment
Rubric Detail
Content
Name: NURS 6630 Week 8 Assignment 1 Short Answer Assessment Rubric
Excellent
Point range: 90–100 |
Good
Point range: 80–89 |
Fair
Point range: 70–79 |
Poor
Point range: 0–69 |
||
In 3 or 4 sentences, explain the appropriate drug therapy for a patient who presents with MDD and a history of alcohol abuse. Which drugs are contraindicated, if any, and why. Be specific. What it is the timeframe that the patient should see resolution of symptoms? | Points Range: 12 (16%) – 13 (17.33%)
The response accurately and clearly explains in detail the appropriate drug therapy for a patient who presents with MDD and a history of alcohol abuse. The response accurately and clearly details which drugs are contraindicated with specific examples. The response accurately and clearly explains in detail the timeframe that the patient should see resolution of symptoms. |
Points Range: 11 (14.67%) – 11 (14.67%)
The response accurately explains the appropriate drug therapy for a patient who presents with MDD and a history of alcohol abuse. The response accurately identifies which drugs are contraindicated with specific examples. The response accurately explains the timeframe that the patient should see resolution of symptoms. |
Points Range: 10 (13.33%) – 10 (13.33%)
The response inaccurately or vaguely explains the appropriate drug therapy for a patient who presents with MDD and a history of alcohol abuse. The response inaccurately or vaguely identifies which drugs are contraindicated with inaccurate or vague examples. The response inaccurately or vaguely explains the timeframe that the patient should see resolution of symptoms. |
Points Range: 0 (0%) – 9 (12%)
The response inaccurately and vaguely explains the appropriate drug therapy for a patient who presents with MDD and a history of alcohol abuse, or is missing. The response inaccurately and vaguely identifies which drugs are contraindicated with inaccurate examples, or is missing. The response inaccurately and vaguely explains the timeframe that the patient should see resolution of symptoms, or is missing. |
|
List four predictors of late onset generalized anxiety disorder. | Points Range: 12 (16%) – 13 (17.33%)
The response accurately and clearly lists in detail four predictors of late-onset generalized anxiety disorder. |
Points Range: 11 (14.67%) – 11 (14.67%)
The response accurately lists four predictors of late-onset generalized anxiety disorder. |
Points Range: 10 (13.33%) – 10 (13.33%)
The response inaccurately or vaguely lists four predictors of late-onset generalized anxiety disorder. |
Points Range: 0 (0%) – 9 (12%)
The response inaccurately and vaguely lists four predictors of late-onset generalized anxiety disorder, or is missing. |
|
List four potential neurobiology causes of psychotic major depression. | Points Range: 12 (16%) – 13 (17.33%)
The response accurately and clearly lists in detail four potential neurobiology causes of psychotic major depression. |
Points Range: 11 (14.67%) – 11 (14.67%)
The response accurately lists four potential neurobiology causes of psychotic major depression. |
Points Range: 10 (13.33%) – 10 (13.33%)
The response inaccurately or vaguely lists four potential neurobiology causes of psychotic major depression. |
Points Range: 0 (0%) – 9 (12%)
The response inaccurately and vaguely lists four potential neurobiology causes of psychotic major depression. |
|
An episode of major depression is defined as a period of time lasting at least 2 weeks. List at least five symptoms required for the episode to occur. Be specific. | Points Range: 12 (16%) – 13 (17.33%)
The response accurately and clearly explains in detail at least five symptoms for the episode of major depression to occur. Specific examples provided fully support the response. |
Points Range: 11 (14.67%) – 11 (14.67%)
The response accurately explains at least five symptoms for the episode of major depression to occur. Specific examples provided support the response. |
Points Range: 10 (13.33%) – 10 (13.33%)
The response inaccurately or vaguely explains at least five symptoms for the episode of major depression to occur. Specific examples provided inaccurately or vaguely support the response. |
Points Range: 0 (0%) – 9 (12%)
The response inaccurately and vaguely explains at least five symptoms for the episode of major depression to occur, or is missing. Specific examples provided do not support the response, or is missing. |
|
List 3 classes of drugs, with a corresponding example for each class, that precipitate insomnia. Be specific. | Points Range: 12 (16%) – 13 (17.33%)
The response accurately and clearly lists in detail 3 classes of drugs, with a corresponding example for each class, that precipitate insomnia. Examples provided fully support the response provided. |
Points Range: 11 (14.67%) – 11 (14.67%)
The response accurately lists 3 classes of drugs, with a corresponding example for each class, that precipitate insomnia. Examples provided support the response provided. |
Points Range: 10 (13.33%) – 10 (13.33%)
The response inaccurately or vaguely lists 3 classes of drugs, with a corresponding example for each class, that precipitate insomnia. Examples provided inaccurately or vaguely support the response provided. |
Points Range: 0 (0%) – 9 (12%)
The response inaccurately and vaguely lists 3 classes of drugs, with a corresponding example for each class, that precipitate insomnia, or is missing. Examples provided do not support the response provided, or is missing. |
|
Written Expression and Formatting – English writing standards: Correct grammar, mechanics, and proper punctuation |
Points Range: 5 (6.67%) – 5 (6.67%)
Uses correct grammar, spelling, and punctuation with no errors. |
Points Range: 4 (5.33%) – 4 (5.33%)
Contains a few (1 or 2) grammar, spelling, and punctuation errors. |
Points Range: 3.5 (4.67%) – 3.5 (4.67%)
Contains several (3 or 4) grammar, spelling, and punctuation errors. |
Points Range: 0 (0%) – 2 (2.67%)
Contains many (≥ 5) grammar, spelling, and punctuation errors that interfere with the reader’s understanding. |
|
Written Expression and Formatting – The paper follows correct APA format for title page, headings, font, spacing, margins, indentations, page numbers, parenthetical/in-text citations, and reference list. | Points Range: 5 (6.67%) – 5 (6.67%)
Uses correct APA format with no errors. |
Points Range: 4 (5.33%) – 4 (5.33%)
Contains a few (1 or 2) APA format errors. |
Points Range: 3.5 (4.67%) – 3.5 (4.67%)
Contains several (3 or 4) APA format errors. |
Points Range: 0 (0%) – 2 (2.67%)
Contains many (≥ 5) APA format errors. |
|
Total Points: 75 | |||||
Name: NURS_6630_Week8_Assignment1_Rubric